Skip to main content

Solutions

Clinical solutions

Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions

Consulting & Commercial

Asset Development Consulting Commercial Positioning Language Services Real World Intelligence Regulatory Affairs Symphony Health data

Outcome Measures
COAs and DHTs – measure what matters

Technologies
Technology solutions from early phase through to post-marketing.
Sectors

Sectors

ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

Read more

Biotech Government and Public Health Medical Device Pharmaceuticals

Biotech
Developing transformative therapies requires a flexible approach.

ICON and You
Partners making a difference.
Therapeutics

Therapeutics

Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Infectious Diseases Internal Medicine & Immunology Oncology

Cross-therapeutics

Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health

Obesity
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

Therapeutics insights
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
Insights

Insights

Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel

Embracing a blended operating model
Maximising efficiency and flexibility with custom outsourcing

De-risking clinical development of precision medicines in oncology
An evolving understanding of cancer biology has resulted in the rise of precision-informed treatment approaches.

Strategies for commercialising oncology treatments for young adults
Oncology treatments tailored specifically for young adults.
News & Events

News & Events

ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

Read more

Press releases In the News Mediakit Awards Events Webinars Social media

Pregnant participants in clinical trials
17 January 2025

Unlocking global strategies with proactive regulatory translation management 
Watch the recording
About ICON

About ICON

Company history Healthcare Intelligence ICON in Asia Pacific ICON in Latin America Leadership Quality

ICON for

Patients Volunteers Investigators Jobs & Careers Investors Suppliers

Sustainability, diversity and charity
ICON Cares is our commitment to making a positive impact on our people, environment and our community.

Healthcare Intelligence
Clinical Research. Evolved.

Careers
Investors
Contact
日本語
简体中文

Home
News & Events
Events
Industry events

Industry events

In this section

In this section

Press releases
In the News
Mediakit
- Facts and figures
- ICON spokespeople
Awards
Events
Webinars
Social media

Connect with us

Contact us
Submit proposal request
Update Email Preferences
Global office locator
ICON on social media

Related Information

Webinars

Workshops

What’s happening in ICON

Site Branding

Contact
About ICON
Results & Reports

For Clients

Therapeutics
Solutions
Insights
Technologies
Content preferences
Office locations

ICON for

Patients
Volunteers
Investigators
Jobs & Careers
Investors
Suppliers

News & Events

Press releases
Mediakit
Events
Social media dashboard

Socials

Linkedin
Facebook
Instagram
Youtube

Legal Footer

© 2024 ICON plc
Disclaimer
Privacy & Data
Cookies

How can we help?

All
Website

Popular search terms:

Biotech
Cell and Gene Therapies
Consulting
Early Clinical
Medical Device
Oncology
Rare & Orphan Diseases
Real World Evidence
Site & Patient Recruitment
Strategic Solutions
Regulatory Intelligence

Categories